FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2905063800> ?p ?o ?g. }

• W2905063800 endingPage "351" @default.
• W2905063800 startingPage "347" @default.
• W2905063800 abstract "Background Treatment of acute cerebrovascular pathology, such as acute ischemic stroke or intracranial aneurysms, presents a challenge if an extracranial or intracranial stent is required; immediate platelet inhibition is vital. To date, there is no standardized approach for antiplatelet inhibition in an acute setting. Objective To report our preliminary experience and lessons learnt using cangrelor in acute neurointervention. Methods A single-arm pilot study was performed to assess the safety and efficacy of cangrelor plus aspirin for platelet inhibition in patients who require acute stenting in the setting of neuroendovascular treatment. Results Eight patients were enrolled between October 2017 and August 2018. Median age was 71 years (53–86). Seven patients were treated in an acute setting according to the stroke protocol at our institution, while one patient was treated for a symptomatic, unruptured aneurysm with flow diversion and coiling. At admission, the median National Institutes of Health Stroke Scale score for the patients with stroke was 12.5 (range 2–22.3). Cangrelor was infused and all patients achieved adequate platelet inhibition (<200 PRU (P2Y12 reaction units)). Six of seven patients with ischemic stroke had a carotid stent placed and one had an intracranial stent deployed in the middle cerebral artery. None of the patients experienced intraprocedural thromboembolic complications, intraprocedural in-stent thrombosis, hemorrhagic complications, or stroke within 24 hours after the intervention. The majority of patients (6/8) had a good clinical outcome at discharge (modified Rankin Scale score 0–2). Conclusions Our findings suggest that cangrelor is a promising alternative in acute stenting for the treatment of cerebrovascular pathology. However, further studies with larger samples are required to accurately elucidate its safety and effectiveness in neuroendovascular procedures." @default.
• W2905063800 created "2018-12-22" @default.
• W2905063800 creator A5000875957 @default.
• W2905063800 creator A5012309281 @default.
• W2905063800 creator A5014450486 @default.
• W2905063800 creator A5027674072 @default.
• W2905063800 creator A5039226026 @default.
• W2905063800 creator A5043193030 @default.
• W2905063800 creator A5055689239 @default.
• W2905063800 creator A5059158975 @default.
• W2905063800 date "2018-12-14" @default.
• W2905063800 modified "2023-10-12" @default.
• W2905063800 title "Safety and efficacy of cangrelor in acute stenting for the treatment of cerebrovascular pathology: preliminary experience in a single-center pilot study" @default.
• W2905063800 cites W1837600385 @default.
• W2905063800 cites W1890882717 @default.
• W2905063800 cites W1949231367 @default.
• W2905063800 cites W1964946379 @default.
• W2905063800 cites W1966433445 @default.
• W2905063800 cites W1978591428 @default.
• W2905063800 cites W1986455514 @default.
• W2905063800 cites W2048479360 @default.
• W2905063800 cites W2071686230 @default.
• W2905063800 cites W2078644068 @default.
• W2905063800 cites W2079311486 @default.
• W2905063800 cites W2107889577 @default.
• W2905063800 cites W2136228924 @default.
• W2905063800 cites W2150655309 @default.
• W2905063800 cites W2277258071 @default.
• W2905063800 cites W2281977179 @default.
• W2905063800 cites W2284016414 @default.
• W2905063800 cites W2315791518 @default.
• W2905063800 cites W2317157216 @default.
• W2905063800 cites W2340818670 @default.
• W2905063800 cites W2600151310 @default.
• W2905063800 cites W2790127125 @default.
• W2905063800 cites W2790502266 @default.
• W2905063800 cites W2792966296 @default.
• W2905063800 doi "https://doi.org/10.1136/neurintsurg-2018-014396" @default.
• W2905063800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30552167" @default.
• W2905063800 hasPublicationYear "2018" @default.
• W2905063800 type Work @default.
• W2905063800 sameAs 2905063800 @default.
• W2905063800 citedByCount "36" @default.
• W2905063800 countsByYear W29050638002019 @default.
• W2905063800 countsByYear W29050638002020 @default.
• W2905063800 countsByYear W29050638002021 @default.
• W2905063800 countsByYear W29050638002022 @default.
• W2905063800 countsByYear W29050638002023 @default.
• W2905063800 crossrefType "journal-article" @default.
• W2905063800 hasAuthorship W2905063800A5000875957 @default.
• W2905063800 hasAuthorship W2905063800A5012309281 @default.
• W2905063800 hasAuthorship W2905063800A5014450486 @default.
• W2905063800 hasAuthorship W2905063800A5027674072 @default.
• W2905063800 hasAuthorship W2905063800A5039226026 @default.
• W2905063800 hasAuthorship W2905063800A5043193030 @default.
• W2905063800 hasAuthorship W2905063800A5055689239 @default.
• W2905063800 hasAuthorship W2905063800A5059158975 @default.
• W2905063800 hasConcept C126322002 @default.
• W2905063800 hasConcept C127413603 @default.
• W2905063800 hasConcept C141071460 @default.
• W2905063800 hasConcept C2776098176 @default.
• W2905063800 hasConcept C2776708134 @default.
• W2905063800 hasConcept C2777628954 @default.
• W2905063800 hasConcept C2777849778 @default.
• W2905063800 hasConcept C2778583881 @default.
• W2905063800 hasConcept C2780645631 @default.
• W2905063800 hasConcept C2780931571 @default.
• W2905063800 hasConcept C3020199598 @default.
• W2905063800 hasConcept C42219234 @default.
• W2905063800 hasConcept C49059817 @default.
• W2905063800 hasConcept C541997718 @default.
• W2905063800 hasConcept C71924100 @default.
• W2905063800 hasConcept C78519656 @default.
• W2905063800 hasConceptScore W2905063800C126322002 @default.
• W2905063800 hasConceptScore W2905063800C127413603 @default.
• W2905063800 hasConceptScore W2905063800C141071460 @default.
• W2905063800 hasConceptScore W2905063800C2776098176 @default.
• W2905063800 hasConceptScore W2905063800C2776708134 @default.
• W2905063800 hasConceptScore W2905063800C2777628954 @default.
• W2905063800 hasConceptScore W2905063800C2777849778 @default.
• W2905063800 hasConceptScore W2905063800C2778583881 @default.
• W2905063800 hasConceptScore W2905063800C2780645631 @default.
• W2905063800 hasConceptScore W2905063800C2780931571 @default.
• W2905063800 hasConceptScore W2905063800C3020199598 @default.
• W2905063800 hasConceptScore W2905063800C42219234 @default.
• W2905063800 hasConceptScore W2905063800C49059817 @default.
• W2905063800 hasConceptScore W2905063800C541997718 @default.
• W2905063800 hasConceptScore W2905063800C71924100 @default.
• W2905063800 hasConceptScore W2905063800C78519656 @default.
• W2905063800 hasIssue "4" @default.
• W2905063800 hasLocation W29050638001 @default.
• W2905063800 hasLocation W29050638002 @default.
• W2905063800 hasOpenAccess W2905063800 @default.
• W2905063800 hasPrimaryLocation W29050638001 @default.
• W2905063800 hasRelatedWork W1973911240 @default.
• W2905063800 hasRelatedWork W1981329287 @default.
• W2905063800 hasRelatedWork W2010454652 @default.
• W2905063800 hasRelatedWork W2096379851 @default.

• next